Search the collection

Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 1
ArticlesPeer ReviewedFull Text
Exclusive Antagonism of the α4β7 Integrin by Vedolizumab Confirms the Gut-selectivity of This Pathway in Primates
Author / Creator:Fedyk, Eric R. ; Wyant, Tim ; Yang, Li-Li ; Csizmadia, Vilmos ; Burke, Kristine ; Yang, Hua ; Kadambi, Vivek J.
Publisher:Oxford, UK: Oxford University Press
Journal title:Inflammatory bowel diseases, 2012-11, Vol.18 (11), p.2107-2119
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 2
Newsletter articlesFull Text
Study: MLN02 produced significant improvement
Publisher:NewsRX LLC
Journal title:Drug Week, 2003, p.491
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 3
Newsletter articlesFull Text
Study: MLN02 produced significant improvement
Publisher:NewsRX LLC
Journal title:Biotech Week, 2003, p.306
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 4
Newsletter articlesFull Text
Study: MLN02 produced significant improvement
Publisher:NewsRX LLC
Journal title:Gastroenterology Week, 2003, p.41
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 5
Newsletter articlesFull Text
Study: MLN02 produced significant improvement
Publisher:NewsRX LLC
Journal title:Clinical Trials Week, 2003, p.38
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 6
Newsletter articlesFull Text
Ulcerative Colitis; Study: MLN02 produced significant improvement: 1
Publisher:Atlanta: NewsRx
Journal title:Gastroenterology Week, 2003, p.41
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 7
Newsletter articlesFull Text
Ulcerative Colitis; Study: MLN02 produced significant improvement
Publisher:Atlanta: NewsRx
Journal title:Drug Week, 2003, p.491
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 8
Newsletter articlesFull Text
Millennium announces phase II data for MLN02
Publisher:NewsRX LLC
Journal title:Drug Week, 2002, p.7
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 9
Newsletter articlesFull Text
Millennium announces phase II data for MLN02
Publisher:NewsRX LLC
Journal title:Biotech Week, 2002, p.60
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 10
Newsletter articlesFull Text
Millennium Pharmaceuticals, Inc.; Study: MLN02 produced significant improvement
Publisher:Atlanta: NewsRx
Journal title:Biotech Week, 2003, p.306
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 11
Newsletter articlesFull Text
Millennium Pharmaceuticals, Inc.; Millennium announces phase II data for MLN02
Publisher:Atlanta: NewsRx
Journal title:Biotech Week, 2002, p.60
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 12
Newsletter articlesFull Text
Millennium Announces Phase II Data for MLN02 in Crohn's Disease
Publisher:New York: PR Newswire Association LLC
Journal title:PR Newswire, 2002, p.1
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 13
Newsletter articlesFull Text
In Phase II Study, Millennium Investigational Drug MLN02 Produced Significant Improvement in Ulcerative Colitis Remission Rates as Compared to Placebo
Publisher:New York: PR Newswire Association LLC
Journal title:PR Newswire, 2003, p.1
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 14
Newsletter articlesFull Text
New England Journal of Medicine Publishes Studies of VELCADE(R) (bortezomib) for Injection in Multiple Myeloma and MLN02 in Ulcerative Colitis
Publisher:New York: PR Newswire Association LLC
Journal title:PR Newswire, 2005, p.1
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 15
Newspaper ArticlesFull Text
New England Journal of Medicine Publishes Studies of VELCADE for Injection in Multiple Myeloma and MLN02 in Ulcerative Colitis
Publisher:PR Newswire Association LLC
Journal title:PR newswire, 2005-06-16
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 16
Newspaper ArticlesFull Text
In Phase II Study, Millennium Investigational Drug MLN02 Produced Significant Improvement in Ulcerative Colitis Remission Rates as Compared to Placebo; -- Novel Monoclonal Antibody Was Well Tolerated...
Publisher:PR Newswire Association LLC
Journal title:PR newswire, 2003-05-21
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 17
ArticlesPeer ReviewedFull Text
Treatment of Ulcerative Colitis with a Humanized Antibody to the α4β7 Integrin
Author / Creator:Feagan, Brian G ; Greenberg, Gordon R ; Wild, Gary ; Fedorak, Richard N ; Paré, Pierre ; McDonald, John W.D ; Dubé, Rejean ; Cohen, Albert ; Steinhart, A. Hillary ; Landau, Steven ; Aguzzi, Rasha A ; Fox, Irving H ; Vandervoort, Margaret K
Publisher:Boston, MA: Massachusetts Medical Society
Journal title:The New England journal of medicine, 2005-06, Vol.352 (24), p.2499-2507
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 18
ArticlesPeer ReviewedFull Text
Treatment of ulcerative colitis with a humanized antibody to the alpha4beta7 integrin
Author / Creator:Feagan, Brian G ; Greenberg, Gordon R ; Wild, Gary ; Fedorak, Richard N ; Paré, Pierre ; McDonald, John W D ; Dubé, Rejean ; Cohen, Albert ; Steinhart, A Hillary ; Landau, Steven ; Aguzzi, Rasha A ; Fox, Irving H ; Vandervoort, Margaret K
Publisher:United States
Journal title:The New England journal of medicine, 2005-06, Vol.352 (24), p.2499-2507
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 19
ArticlesPeer ReviewedFull Text
Vedolizumab for the Treatment of Active Ulcerative Colitis: A Randomized Controlled Phase 2 Dose-ranging Study
Author / Creator:Parikh, Asit ; Leach, Timothy ; Wyant, Tim ; Scholz, Catherine ; Sankoh, Serap ; Mould, Diane R. ; Ponich, Terry ; Fox, Irving ; Feagan, Brian G.
Publisher:Oxford, UK: Oxford University Press
Journal title:Inflammatory bowel diseases, 2012-08, Vol.18 (8), p.1470-1479
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 20
ArticlesPeer ReviewedFull Text
Long-term Clinical Experience with Vedolizumab in Patients with Inflammatory Bowel Disease
Author / Creator:Parikh, Asit ; Fox, Irving ; Leach, Timothy ; Xu, Jing ; Scholz, Catherine ; Patella, Michael ; Feagan, Brian G.
Publisher:Oxford, UK: Oxford University Press
Journal title:Inflammatory bowel diseases, 2013-07, Vol.19 (8), p.1691-1699
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.

Showing 1 to 20 of 35 results

Search the collection

Export record to excel

Export this record

Export record to excel

Exclusive Antagonism of the α4β7 Integrin by Vedolizumab Confirms the Gut-selectivity of This Pathway in Primates

Export this record

Export record to excel

Study: MLN02 produced significant improvement

Export this record

Export record to excel

Study: MLN02 produced significant improvement

Export this record

Export record to excel

Study: MLN02 produced significant improvement

Export this record

Export record to excel

Study: MLN02 produced significant improvement

Export this record

Export record to excel

Ulcerative Colitis; Study: MLN02 produced significant improvement: 1

Export this record

Export record to excel

Ulcerative Colitis; Study: MLN02 produced significant improvement

Export this record

Export record to excel

Millennium announces phase II data for MLN02

Export this record

Export record to excel

Millennium announces phase II data for MLN02

Export this record

Export record to excel

Millennium Pharmaceuticals, Inc.; Study: MLN02 produced significant improvement

Export this record

Export record to excel

Millennium Pharmaceuticals, Inc.; Millennium announces phase II data for MLN02

Export this record

Export record to excel

Millennium Announces Phase II Data for MLN02 in Crohn's Disease

Export this record

Export record to excel

In Phase II Study, Millennium Investigational Drug MLN02 Produced Significant Improvement in Ulcerative Colitis Remission Rates as Compared to Placebo

Export this record

Export record to excel

New England Journal of Medicine Publishes Studies of VELCADE(R) (bortezomib) for Injection in Multiple Myeloma and MLN02 in Ulcerative Colitis

Export this record

Export record to excel

New England Journal of Medicine Publishes Studies of VELCADE for Injection in Multiple Myeloma and MLN02 in Ulcerative Colitis

Export this record

Export record to excel

In Phase II Study, Millennium Investigational Drug MLN02 Produced Significant Improvement in Ulcerative Colitis Remission Rates as Compared to Placebo; -- Novel Monoclonal Antibody Was Well Tolerated...

Export this record

Export record to excel

Treatment of Ulcerative Colitis with a Humanized Antibody to the α4β7 Integrin

Export this record

Export record to excel

Treatment of ulcerative colitis with a humanized antibody to the alpha4beta7 integrin

Export this record

Export record to excel

Vedolizumab for the Treatment of Active Ulcerative Colitis: A Randomized Controlled Phase 2 Dose-ranging Study

Export this record

Export record to excel

Long-term Clinical Experience with Vedolizumab in Patients with Inflammatory Bowel Disease

Refine your search